With the UK’s default to leave the EU without a deal, there are a number of steps businesses in the life sciences sector should take to prepare. Many companies in the sector are faced with simultaneously navigating an increasingly complex regulatory environment while trying to mitigate as much as possible the significant impact of Brexit – including the effects of weak drug development pipelines, access to talent, supply chain disruption and potentially reduced research and development (R&D) funding.
Only logged in customers who have purchased this product may leave a review.
You may also like
Organizations- and their Technology and Cyber Risk Management (TCRM) functions- are being buffeted by changing dynamics bringing ever-increasing risks: mounting regulatory pressures, innovative new technology, an evolving workforce in need of new skills, and organizational shifts that create cyber and information security challenges.
Four Key steps to fuel a proactive tech and cyber risk function$0.00 KPMG
New technologies are fundamentally disrupting the business model for consumer products companies around the world. Relationships between manufacturers and retailers – and the consumers they share – are changing, and new business models are emerging. This is a challenge, certainly, but also a tremendous opportunity.
Achieving Profitable Growth in Consumer Products$0.00 Alix Partner
On display in the Berlin Air Show in June 2016 was ‘Thor’ – the small Airbus marvel that is the world’s first aircraft wholly produced by additive manufacturing (AM). Windowless weighing in at just 21 kilos (46 pounds) and less than four meters (13 feet) long, the drone Thor – short for “Test of High-tech Objectives in Reality” – resembles a large, white model airplane.
3D Printing$0.00 Ipsos Business consulting
Trouble with Conavigo
Want to refine your results?
Help with Sourcing
Need help with your Sourcing?